Vor Biopharma (VOR) Shares Outstanding (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Shares Outstanding (Entity) of $43.0 million for Q1 2026, up 589.0% year-over-year from $6.2 million in Q1 2025, and up 335.7% quarter-over-quarter from $9.9 million in Q4 2025.
Vor Biopharma (VOR) Shares Outstanding (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Shares Outstanding (Entity) for 7 consecutive years, with $43.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 589.0% year-over-year to $43.0 million; the TTM figure through Mar 2026 stood at $43.0 million (up 589.0% YoY), while the FY2025 annual figure was $9.9 million, up 187.37% from the prior year.
- Shares Outstanding (Entity) rose to $43.0 million in Q1 2026 per VOR's latest filing, from $9.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $43.0 million in Q1 2026 and bottomed at $1.9 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $6.3 million across 5 years, with a median of $3.4 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) grew 1.18% — and 2026, when it surged 589.0%.
- Vor Biopharma's Shares Outstanding (Entity) stood at $2.0 million in 2022, then soared by 71.68% to $3.4 million in 2023, then increased by 1.18% to $3.4 million in 2024, then jumped by 187.37% to $9.9 million in 2025, then surged by 335.7% to $43.0 million in 2026.
- Business Quant data shows VOR's Shares Outstanding (Entity) at $43.0 million in Q1 2026, $9.9 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 54.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.30 Mn |
| Mar 31, 2026 | 43.01 Mn |
| Dec 31, 2025 | 9.87 Mn |
| Sep 30, 2025 | 6.68 Mn |
| Jun 30, 2025 | 6.26 Mn |
| Mar 31, 2025 | 6.24 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 3.36 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.35 Mn |
| Mar 31, 2023 | 3.31 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 1.87 Mn |
| Mar 31, 2022 | 1.86 Mn |
| Dec 31, 2021 | 1.67 Mn |
| Sep 30, 2021 | 1.85 Mn |